GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » TaiMed Biologics Inc (ROCO:4147) » Definitions » Sale Of Investment

TaiMed Biologics (ROCO:4147) Sale Of Investment : NT$0.2 Mil (TTM As of Mar. 2024)


View and export this data going back to 2010. Start your Free Trial

What is TaiMed Biologics Sale Of Investment?

TaiMed Biologics's sale of investment for the three months ended in Mar. 2024 was NT$0.0 Mil. It means TaiMed Biologics gained NT$0.0 Mil from selling investments. TaiMed Biologics's sale of investment for the trailing twelve months (TTM) ended in Mar. 2024 was NT$0.2 Mil.

Compared with last quarter (NT$8.9 Mil in Dec. 2023 ), TaiMed Biologics gained less money from selling investments in Mar. 2024 (NT$0.0 Mil).


TaiMed Biologics Sale Of Investment Historical Data

The historical data trend for TaiMed Biologics's Sale Of Investment can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

TaiMed Biologics Sale Of Investment Chart

TaiMed Biologics Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Sale Of Investment
Get a 7-Day Free Trial Premium Member Only Premium Member Only 504.38 289.98 222.30 110.88 30.50

TaiMed Biologics Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Sale Of Investment Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 30.31 91.60 -100.33 8.93 -

TaiMed Biologics Sale Of Investment Calculation

Sale of Investments represents cash inflow on the sale of investments in securities.

Sale Of Investment for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was NT$0.2 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


TaiMed Biologics Sale Of Investment Related Terms

Thank you for viewing the detailed overview of TaiMed Biologics's Sale Of Investment provided by GuruFocus.com. Please click on the following links to see related term pages.


TaiMed Biologics (ROCO:4147) Business Description

Traded in Other Exchanges
N/A
Address
No. 607, Ruiguang Road, 3rd Floor, Neihu District, Taipei, TWN, 11492
TaiMed Biologics Inc is a Taiwan-based biotechnology company. It is engaged in the discovery, development, and delivery of medicines for infectious disease. It capitalizes on its intellectual, extensive expertise, and management resources to develop a health-care product pipeline that benefits patients, rewards investors, and propels to prominence in the biotechnology industry. The company's products pipeline includes TMB-365, VRC07-523LS, and others.

TaiMed Biologics (ROCO:4147) Headlines

No Headlines